Literature DB >> 31139294

Clinical and Procedural Effects of Transitioning to Contact Force Guided Ablation for Atrial Fibrillation.

Daniel R Frisch1, Sean J Dikdan1.   

Abstract

BACKGROUND: A major innovation in atrial fibrillation (AF) ablation has been the introduction of contact force (CF) sensing catheters.
OBJECTIVE: To evaluate procedural and clinical effects of transitioning to CF-guided AF ablation.
METHODS: Consecutive AF ablation patients were studiedduring the period of time of transitioning from a non-CF to CF sensing catheter. Procedural data recorded was total radiofrequency time, time to isolate the left pulmonary veins (LPVs), and time to isolate the right pulmonary veins (RPVs). Clinically, the 3 and 12-month maintenance of sinus rhythm was noted and compared by: paroxysmal vs. persistent AF; CT scan LA volume more or less than 150 cc; CHA2DS2VASC more or less than 2; and LVEF more or less than 55%. Safety data was recorded as well.
RESULTS: Total ablation times were shorter (113 vs.146 min, p=0.011)when using the CF catheters compared to non-CF ablations. This was driven by a decrease in both LPV (46 vs.72 min, p<0.001) and RPV time (54 vs. 75 min, p=0.002).The use of CF catheter did not change the overall percentage of patients in sinus rhythm at 3 and 12-months of follow up. However, sinus rhythm was more frequent at 12 months with CF ablation inpatients with an LA volume of more than 150 cc when compared to non-CF ablation (84.6% and 52.4%, p=0.03). There was no difference in outcomes with stratification by CHA2DS2VASC score or LVEF. No significant difference in complications was noted.
CONCLUSIONS: For AF ablation, the initial use of CF-sensing technology reduced procedure times with similar overall sinus rhythm maintenance at 3 and 12 months. CF improved 12-month outcomes in patients with an enlarged LA.

Entities:  

Keywords:  Ablation; Atrial Fibrillation; Contact Force

Year:  2019        PMID: 31139294      PMCID: PMC6533825          DOI: 10.4022/jafib.2081

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  22 in total

1.  The July phenomenon revisited: new insights on a lore of academic medicine.

Authors:  Gary E Rosenthal; Mary Vaughan-Sarrazin
Journal:  Circulation       Date:  2013-10-23       Impact factor: 29.690

2.  Comparison of lesion formation between contact force-guided and non-guided circumferential pulmonary vein isolation: a prospective, randomized study.

Authors:  Masaomi Kimura; Shingo Sasaki; Shingen Owada; Daisuke Horiuchi; Kenichi Sasaki; Taihei Itoh; Yuji Ishida; Takahiko Kinjo; Hirofumi Tomita; Ken Okumura
Journal:  Heart Rhythm       Date:  2014-03-18       Impact factor: 6.343

3.  Pulmonary vein isolation using "contact force" ablation: the effect on dormant conduction and long-term freedom from recurrent atrial fibrillation--a prospective study.

Authors:  Jason G Andrade; George Monir; Scott J Pollak; Paul Khairy; Marc Dubuc; Denis Roy; Mario Talajic; Marc Deyell; Léna Rivard; Bernard Thibault; Peter G Guerra; Stanley Nattel; Laurent Macle
Journal:  Heart Rhythm       Date:  2014-07-25       Impact factor: 6.343

4.  Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study.

Authors:  Petr Neuzil; Vivek Y Reddy; Josef Kautzner; Jan Petru; Dan Wichterle; Dipen Shah; Hendrik Lambert; Aude Yulzari; Erik Wissner; Karl-Heinz Kuck
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-03-20

5.  Trainee inexperience is associated with longer procedure times but no increase in complications for cardiac device implantation.

Authors:  Ata Soleimani Rahbar; Jonathan C Hsu; Frederick T Han; NhuNhu Nguyen; Minkyung Kwon; Peyman N Azadani; Gregory M Marcus; Byron K Lee
Journal:  Heart Rhythm       Date:  2013-09-06       Impact factor: 6.343

6.  The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study.

Authors:  Vivek Y Reddy; Dipen Shah; Josef Kautzner; Boris Schmidt; Nadir Saoudi; Claudia Herrera; Pierre Jaïs; Gerhard Hindricks; Petr Peichl; Aude Yulzari; Hendrik Lambert; Petr Neuzil; Andrea Natale; Karl-Heinz Kuck
Journal:  Heart Rhythm       Date:  2012-07-20       Impact factor: 6.343

7.  Impact of left atrial volume on outcomes of pulmonary vein isolation in patients with non-paroxysmal (persistent) and paroxysmal atrial fibrillation.

Authors:  Vaibhav Amin; Jonathan Finkel; Ethan Halpern; Daniel R Frisch
Journal:  Am J Cardiol       Date:  2013-07-05       Impact factor: 2.778

8.  The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries.

Authors:  Sana M Al-Khatib; F Lee Lucas; James G Jollis; David J Malenka; David E Wennberg
Journal:  J Am Coll Cardiol       Date:  2005-09-23       Impact factor: 24.094

9.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.

Authors:  Carlos A Morillo; Atul Verma; Stuart J Connolly; Karl H Kuck; Girish M Nair; Jean Champagne; Laurence D Sterns; Heather Beresh; Jeffrey S Healey; Andrea Natale
Journal:  JAMA       Date:  2014-02-19       Impact factor: 56.272

10.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.

Authors:  David J Wilber; Carlo Pappone; Petr Neuzil; Angelo De Paola; Frank Marchlinski; Andrea Natale; Laurent Macle; Emile G Daoud; Hugh Calkins; Burr Hall; Vivek Reddy; Giuseppe Augello; Matthew R Reynolds; Chandan Vinekar; Christine Y Liu; Scott M Berry; Donald A Berry
Journal:  JAMA       Date:  2010-01-27       Impact factor: 56.272

View more
  2 in total

Review 1.  A Systematic Review and Meta-Analysis of the Direct Comparison of Second-Generation Cryoballoon Ablation and Contact Force-Sensing Radiofrequency Ablation in Patients with Paroxysmal Atrial Fibrillation.

Authors:  Yoga Waranugraha; Ardian Rizal; Yoga Yuniadi
Journal:  J Pers Med       Date:  2022-02-17

2.  High-power short-duration versus standard-power standard-duration settings for repeat atrial fibrillation ablation.

Authors:  Joey Junarta; Sean J Dikdan; Naman Upadhyay; Sairamya Bodempudi; Michael Y Shvili; Daniel R Frisch
Journal:  Heart Vessels       Date:  2021-11-30       Impact factor: 1.814

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.